• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗坏血酸盐是大鼠肝脏和肾脏超滤液中铬(VI)的主要还原剂。

Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.

作者信息

Standeven A M, Wetterhahn K E

机构信息

Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH.

出版信息

Carcinogenesis. 1991 Sep;12(9):1733-7. doi: 10.1093/carcin/12.9.1733.

DOI:10.1093/carcin/12.9.1733
PMID:1893533
Abstract

Chromium (VI) reductase activity was measured in ultrafiltrates of rat liver and kidney after various pretreatments in vitro at 37 degrees C and pH 7.0. Preincubation of ultrafiltrates with L-ascorbate oxidase (EC 1.10.3.3), which specifically eliminated ascorbate, blocked approximately 80% of the Cr(VI) reductase activity. Heat-denatured ascorbate oxidase had no effect on Cr(VI) reductase activity in ultrafiltrates. Preincubation of ultrafiltrates with N-ethylmaleimide, which non-specifically blocked sulfhydryls, including reduced glutathione, decreased Cr(VI) reductase activity by only 20%. Treatment of male Sprague-Dawley rats with phorone decreased non-protein sulfhydryl (NPSH) levels in rat liver by greater than 90% and tripled reduced ascorbate levels 2 h after treatment. Ultrafiltrates of liver prepared from phorone-treated rats had twice the Cr(VI) reductase activity of control ultrafiltrates, and greater than 95% of this activity could be blocked by preincubation with ascorbate oxidase. Treatment of rats with sodium dichromate (20 mg/kg) caused a significant decrease in ascorbate levels in kidney but not liver, and no change in NPSH levels in kidney or liver, 15 min after treatment. We conclude that ascorbate is the major reductant of Cr(VI) in rat liver and kidney ultrafiltrates and may well be the major non-enzymatic reductant of Cr(VI) in rat liver and kidney in vivo.

摘要

在37摄氏度和pH 7.0条件下对大鼠肝脏和肾脏的超滤液进行各种体外预处理后,测定了其中铬(VI)还原酶的活性。超滤液与特异性消除抗坏血酸的L-抗坏血酸氧化酶(EC 1.10.3.3)预孵育,可阻断约80%的Cr(VI)还原酶活性。热变性的抗坏血酸氧化酶对超滤液中的Cr(VI)还原酶活性没有影响。超滤液与N-乙基马来酰亚胺预孵育,N-乙基马来酰亚胺非特异性地阻断包括还原型谷胱甘肽在内的巯基,使Cr(VI)还原酶活性仅降低20%。用佛尔酮处理雄性Sprague-Dawley大鼠,2小时后大鼠肝脏中的非蛋白巯基(NPSH)水平降低超过90%,还原型抗坏血酸水平增加两倍。用佛尔酮处理的大鼠肝脏制备的超滤液的Cr(VI)还原酶活性是对照超滤液的两倍,且该活性的95%以上可通过与抗坏血酸氧化酶预孵育而被阻断。用重铬酸钠(20 mg/kg)处理大鼠15分钟后,肾脏中的抗坏血酸水平显著降低,但肝脏中的抗坏血酸水平未降低,肾脏和肝脏中的NPSH水平也没有变化。我们得出结论,抗坏血酸是大鼠肝脏和肾脏超滤液中Cr(VI)的主要还原剂,很可能也是大鼠肝脏和肾脏体内Cr(VI)的主要非酶还原剂。

相似文献

1
Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.抗坏血酸盐是大鼠肝脏和肾脏超滤液中铬(VI)的主要还原剂。
Carcinogenesis. 1991 Sep;12(9):1733-7. doi: 10.1093/carcin/12.9.1733.
2
Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.抗坏血酸盐是大鼠肺超滤液和细胞溶质中铬(VI)的主要还原剂,并在体外介导铬与DNA的结合。
Carcinogenesis. 1992 Aug;13(8):1319-24. doi: 10.1093/carcin/13.8.1319.
3
In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).在给予六价铬处理后,抗坏血酸和谷胱甘肽对成骨障碍性史氏大鼠肝脏和肾脏中铬摄取、五价铬形成、铬与DNA结合以及8-羟基-2'-脱氧鸟苷的体内影响。
Carcinogenesis. 1999 Jul;20(7):1267-75. doi: 10.1093/carcin/20.7.1267.
4
Nonenzymatic bioreduction in rat liver and kidney of nitroxyl spin labels, potential contrast agents in magnetic resonance imaging.大鼠肝脏和肾脏对硝酰自旋标记物的非酶促生物还原,磁共振成像中的潜在造影剂。
Drug Metab Dispos. 1987 Mar-Apr;15(2):155-60.
5
Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.谷胱甘肽在大鼠六价铬代谢及毒性中的可能作用
Pharmacol Toxicol. 1991 Jun;68(6):469-76. doi: 10.1111/j.1600-0773.1991.tb01272.x.
6
Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.P450 蛋白酶对六价铬的还原代谢及蛋白结合作用。
Carcinogenesis. 1991 May;12(5):825-31. doi: 10.1093/carcin/12.5.825.
7
Effect of chromium (VI) exposure on antioxidant defense status and trace element homeostasis in acute experiment in rat.大鼠急性实验中六价铬暴露对抗氧化防御状态和微量元素稳态的影响。
Toxicol Ind Health. 2015 Nov;31(11):1044-50. doi: 10.1177/0748233713487244. Epub 2013 Apr 26.
8
Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney.钒(V)和/或铬(III)对大鼠肝脏和肾脏中L-抗坏血酸、谷胱甘肽以及铁、锌和铜水平的影响。
J Toxicol Environ Health A. 2007 Apr 15;70(8):696-704. doi: 10.1080/15287390601187906.
9
Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.体外实验中,抗坏血酸盐对六价铬的还原作用会导致铬与DNA结合以及DNA链断裂。
Biochemistry. 1995 Jan 24;34(3):910-9. doi: 10.1021/bi00003a025.
10
In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V).六价铬对小鼠的体内肾毒性。谷胱甘肽和五价铬的作用。
Biol Trace Elem Res. 1991 Oct;31(1):21-31. doi: 10.1007/BF02990356.

引用本文的文献

1
Nuclear SUMOylation and Proteotoxic Stress Responses to Metals with Different Ligand Preferences.核小泛素样修饰以及对具有不同配体偏好性的金属的蛋白质毒性应激反应
Chem Res Toxicol. 2025 May 19;38(5):942-953. doi: 10.1021/acs.chemrestox.5c00040. Epub 2025 Apr 17.
2
Chemical mechanisms of DNA damage by carcinogenic chromium(VI).致癌铬(VI)导致 DNA 损伤的化学机制。
Adv Pharmacol. 2023;96:25-46. doi: 10.1016/bs.apha.2022.07.003. Epub 2022 Aug 26.
3
Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe?
过渡金属肾毒性中的肾脏缺氧-HIF-PHD-EPO 信号:是敌是友?
Arch Toxicol. 2022 Jun;96(6):1573-1607. doi: 10.1007/s00204-022-03285-3. Epub 2022 Apr 21.
4
Toxicological Antagonism among Welding Fume Metals: Inactivation of Soluble Cr(VI) by Iron.焊接烟尘金属的毒理学拮抗作用:铁对可溶性 Cr(VI)的失活作用。
Chem Res Toxicol. 2018 Nov 19;31(11):1172-1184. doi: 10.1021/acs.chemrestox.8b00182. Epub 2018 Nov 6.
5
Carcinogenicity of chromium and chemoprevention: a brief update.铬的致癌性与化学预防:简要更新
Onco Targets Ther. 2017 Aug 16;10:4065-4079. doi: 10.2147/OTT.S139262. eCollection 2017.
6
Variation in Extracellular Detoxification Is a Link to Different Carcinogenicity among Chromates in Rodent and Human Lungs.细胞外解毒作用的差异是铬酸盐在啮齿动物和人类肺部产生不同致癌性的一个关联因素。
Chem Res Toxicol. 2017 Sep 18;30(9):1720-1729. doi: 10.1021/acs.chemrestox.7b00172. Epub 2017 Aug 20.
7
Oral Chromium Exposure and Toxicity.口服铬暴露与毒性。
Curr Environ Health Rep. 2015 Sep;2(3):295-303. doi: 10.1007/s40572-015-0054-z.
8
Temporal changes in rat liver gene expression after acute cadmium and chromium exposure.急性镉和铬暴露后大鼠肝脏基因表达的时间变化。
PLoS One. 2015 May 19;10(5):e0127327. doi: 10.1371/journal.pone.0127327. eCollection 2015.
9
Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics.通过抗坏血酸和非抗坏血酸还原对铬(VI)代谢的不同ATM信号传导:对体外模型和毒理基因组学的影响。
Environ Health Perspect. 2016 Jan;124(1):61-6. doi: 10.1289/ehp.1409434. Epub 2015 May 15.
10
DNA double-strand breaks by Cr(VI) are targeted to euchromatin and cause ATR-dependent phosphorylation of histone H2AX and its ubiquitination.六价铬导致的DNA双链断裂靶向于常染色质,并引起组蛋白H2AX的ATR依赖性磷酸化及其泛素化。
Toxicol Sci. 2015 Jan;143(1):54-63. doi: 10.1093/toxsci/kfu207. Epub 2014 Oct 6.